Table 4.
Compd | R4 | R5 | IC50 (μM) |
---|---|---|---|
D1 | 0.477 ± 0.078 | ||
D2 | 1.005 ± 0.136 | ||
D3 | 0.290 ± 0.030 | ||
D4 | 0.386 ± 0.017 | ||
D5 | 0.692 ± 0.119 | ||
D6 | 0.107 ± 0.023 | ||
D7 | 0.239 ± 0.028 | ||
D8 | 0.100 ± 0.012 | ||
D9 | 0.284 ± 0.028 | ||
D10 | 0.131 ± 0.022 | ||
D11 | 0.502 ± 0.038 | ||
D12 | 0.466 ± 0.040 | ||
C7 | 0.085 ± 0.006 |
C7 was used as the positive control. Inhibitory activity against SARS-CoV-2 Mprowas determined with the FRET protease activity assay. Values represent a mean ± SD of at least three independent experiments.